Biopharmx (NYSEAMERICAN:BPMX) Stock Price Down 9.5%

Shares of Biopharmx Corp (NYSEAMERICAN:BPMXGet Free Report) were down 9.5% on Monday . The company traded as low as $5.47 and last traded at $6.12. Approximately 336,508 shares traded hands during trading, a decline of 84% from the average daily volume of 2,150,348 shares. The stock had previously closed at $6.76.

Biopharmx Stock Performance

Biopharmx Company Profile

(Get Free Report)

BioPharmX Corporation, a specialty pharmaceutical company, develops and commercializes novel prescription and over-the-counter (OTC) products that address dermatology and women's health markets. The company offers VI2OLET, an OTC molecular iodine dietary supplement that addresses cyclic breast discomfort, as well as alleviates the symptoms of fibrocystic breast condition (FBC).

Read More

Receive News & Ratings for Biopharmx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biopharmx and related companies with MarketBeat.com's FREE daily email newsletter.